What Has Been the Growth of the Stem Cell Therapy Market So Far?
The stem cell therapy market has seen considerable growth due to a variety of factors.
• The market size for stem cell therapy has seen a significant increase in recent times. It is projected to rise from $7.86 billion in 2024 to about $9.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.7%.
Factors contributing to this upward trend in the historic period include an escalating number of chronic diseases, greater funds obtained from governmental and private entities, swift expansion in emerging markets, escalating investments in gene and cell therapies, rise in healthcare spending, and increased expenditures in pharmaceutical research and development.
How Will The Stem Cell Therapy Market Size Evolve In The Foreseeable Future?
The stem cell therapy market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a swift surge is anticipated in the market size of stem cell therapy, which is projected to reach $14.6 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.1%.
This anticipated escalation during the prediction period can be attributed to factors such as enhanced government backing, a rapidly aging population, elevated R&D expenditures, and amplified healthcare expenses. During the forecast duration, key trends involve closely tracking developments in mesenchymal stem cell therapy with the intention of leveraging innovative breakthroughs in the sector. To further foster product innovation and revenue growth, market participants are suggested to collaborate and merge with other entities. They should also contemplate investments in the development of ipsc-derived nk cells for patient treatment. Providers in the stem cell therapy market must focus on the development of stem cell therapy, especially for cancer, in order to gain a competitive edge over competitors dealing in somatic cells. Also, by utilizing artificial intelligence, companies in the stem cell therapy market can enhance the quality and safety of their products while boosting production efficiency.
What Are the Critical Driver Fuelling the Stem Cell Therapy Market's Growth?
The escalating frequency of chronic illnesses is propelling the stem cell therapy market's expansion. Sedentary lifestyles with extended hours at work, coupled with poor dietary and drinking habits, increase the widespread impact of chronic diseases, thereby fueling the demand for stem cell therapy. A United Nations report predicts that by 2030, approximately 70% of all deaths will be attributed to chronic diseases. The overall impact of chronic diseases globally could also amount to around 60%. This increasing incidence of chronic illnesses is projected to stimulate the growth of the stem cell therapy market.
What Are The Core Segments Of The Globa Stem Cell Therapy Market?
The stem cell therapy market covered in this report is segmented –
1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
4) By End-Users: Hospitals And Clinics, Research Centers, Others.
Subsegments:
1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells
2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue
Pre-Book The Stem Cell Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Stem Cell Therapy Market?
Firms in the stem cell therapy industry are progressively making strategic alliances. These are mutually advantageous arrangements between two firms that do not directly compete against one another. To illustrate, in May 2022, a strategic collaboration was formed between SQZ Biotechnologies, a biotech company from the US, and STEMCELL Technologies Inc., a Canadian biotech firm. The goal of this partnership was the development and marketing of a research-only microfluidic intracellular delivery system, which is based on SQZ's Cell Squeeze technology. This technology will offer advanced cell engineering capabilities for preclinical research in the life sciences community. These companies plan to showcase key discoveries relating to the RUO system's ability to efficiently deliver payloads to primary immune cell types, as well as advances in cell engineering utilizing mRNA and CRISPR/Cas9 in hematopoietic stem cells.
Who Are the Key Players in the Stem Cell Therapy Market?
Major companies operating in the stem cell therapy market include:
• Fujifilm Holding Corporation
• Thermo Fisher Scientific Inc.
• Takara Bio Inc.
• MEDIPOST Co. Ltd.
• Astellas Pharma Inc.
• Catalent. Inc.
• Pharmicell Co. Ltd.
• JCR Pharmaceuticals Co. Ltd.
• Stemedica Cell Technologies. Inc.
• Pluristem Technologies Ltd
• Becton Dickinson Private Limited
• Stem Cell Technologies India Pvt. Ltd
• Cordlife India Pvt. Ltd
• Lifecell International Pvt. Ltd
• Stemcyte India Therapeutics Private Limited
• Stempeutics Research Private Limited
• Anterogen Co. Ltd
• Tonghua Dongbao Pharmaceutical Co
• China Biologic Products Holdings Inc
• Astrazenaca
• Ablbio
• Henlius
• China Regenerative Medicine International
• Innovent Biologics
• Bio-Thera
• Hisun Pharma
• 3sbio
• Beijing Shuanglu Pharmaceuticals
• Qilu Pharmaceutical
• Shanghai Fosun Pharmaceuticals
• Cellerix
• Cellgenix
• Nsgene
• Tigenix
• Renuron Group
• Smart Cells And Genenta Science
• Amsterdam Molecular Therapeutics (Amt)
• Ark Therapeutics
• Arthrogen Bv
• Diamyd Medical Ab
• Oxford Biomedica
• Transgene
• Mabion
• Pure Biologics
• Oncoarendi Therapeutics
• Celon Pharma
• Becton Dickinson And Company
• Osiris Therapeutics
• Capricortherapeutics
• Cellular Dynamics Discgenics
• Takeda Pharmaceuticals
• Kolon Tissue Gene
• Athersys
• Cyro-Cell International
• Geron Corporation
• Mesoblast Ltd
• Astrom Biosciences Inc
• Invitrogen
• Cytori Therapeutics Inc
• Nuvasive Inc
• Bristol-Myers Squibb Aldagen Inc
• Caladrius Biosciences Inc
• Biogen Sa
• Daiichi Sankyo Co. Ltd
• Gamida Cell Ltd
• Gilead Sciences. Inc.
• Novartis Ag
• Pfizer
• Sanofi S.A.
What are the Regional Insights into the Stem Cell Therapy Market?
North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
